a)
This test applies to various external parts of the complete dose area measurement equipment which may be touched by the
OPERATOR during a normal measurement (i.e. not to those parts of the IONIZATION CHAMBER and MEASURING
ASSEMBLY that are normally exposed in the radiation beam).
b)
The interface between the PATIENT physiological signal simulation, if used, and the ME EQUIPMENT or ME SYSTEM
shall be located within 0,1 m of the vertical plane of the uniform field area in one orientation of the ME EQUIPMENT or
ME SYSTEM.
c)
ME EQUIPMENT and ME SYSTEMS that intentionally receive RF electromagnetic energy for the purpose of their operation
shall be tested at the frequency of reception. Testing may be performed at other modulation frequencies identified by the
RISK MANAGEMENT PROCESS. This test assesses the BASIC SAFETY and ESSENTIAL PERFORMANCE of an
intentional receiver when an ambient signal is in the passband. It is understood that the receiver might not achieve normal
reception during the test.
d)
Testing may be performed at other modulation frequencies identified by the RISK MANAGEMENT PROCESS.
e)
Applies only to ME EQUIPMENT and ME SYSTEMS with magnetically sensitive components or circuitry.
f)
During the test, the ME EQUIPMENT or ME SYSTEM may be powered at any NOMINAL input voltage, but with the same
frequency as the test signal.
g)
Before modulation is applied.
h)
This test level assumes a minimum distance between the ME EQUIPMENT or ME SYSTEM and sources of power
frequency magnetic field of at least 15 cm. If the RISK ANALYSIS shows that the ME EQUIPMENT or ME SYSTEM will be
used closer than 15 cm to sources of power frequency magnetic field, the IMMUNITY TEST LEVEL shall be adjusted as
appropriate for the minimum expected distance.
To Next Page
